Income Taxes (Tables)

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Domestic and Foreign

Income (loss) from continuing operations before income taxes and equity income as reported on the Consolidated Statements of Operations consists of the following:

(In thousands)	2025		2024		2023
U.S.	$	(107,774)	$	(60,713)	$	(19,870)
International	(29,045)		(42,867)		(25,977)
Total income (loss) from continuing operations before income taxes and equity income	$	(136,819)	$	(103,580)	$	(45,847)

Schedule of Components of Income Tax Expense (Benefit)

Income tax expense (benefit) as reported on the Consolidated Statements of Operations consists of the following:

(In thousands)	2025		2024		2023
Income tax expense (benefit):
Currently payable:
U.S. federal	$	252	$	1,020	$	(637)
U.S. state	1,979		2,701		3,591
International	19,511		24,884		23,801
Total income taxes currently payable	21,742		28,605		26,755
Deferred U.S. federal	(7,619)		(4,018)		5,679
Deferred U.S. state	1,254		(2,967)		(1,414)
Deferred international	7,609		(4,786)		3,510
Total deferred income tax expense	1,244		(11,771)		7,775
Total income tax expense (benefit) from continuing operations	$	22,986	$	16,834	$	34,530

Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the Income tax benefit (expense) from continuing operations to the amount computed by applying the 21% statutory U.S. federal income tax rate to Income (loss) from continuing operations before income taxes and equity income for years prior to the adoption of ASU 2023-09 is as follows:

(In thousands)	2024		2023
U.S. federal income tax expense (benefit), at statutory tax rate of 21%	$	(21,751)	$	(9,628)
U.S. state income taxes, net of federal income tax benefit	(1,272)		611
U.S. other domestic deductions and credits	(1,241)		(1,092)
Difference in effective tax rates on international earnings and remittances	29,735		25,240
Uncertain tax position contingencies and settlements	(51)		1,688
Changes in realization of deferred tax assets	10,366		14,498
U.S. non-deductible expenses	1,574		1,016
Nondeductible goodwill charges	3,676		—
PP&E / Intangible asset impairment	—		2,961
State deferred tax rate changes	(63)		304
Foreign derived intangible income deduction	—		(2,199)
Share-based compensation	1,967		1,131
Capital loss	(6,106)		—
Income tax expense (benefit) from continuing operations	$	16,834	$	34,530

Schedule of Deferred Tax Assets and Liabilities

The income tax effects of the temporary differences giving rise to the Company's deferred tax assets and liabilities at December 31, 2025 and 2024 are as follows:

	2025 (a)				2024 (a)
(In thousands)	Asset		Liability		Asset		Liability
Depreciation and amortization	$	—	$	46,207	$	—	$	47,816
Right-of-use assets	—		32,523		—		22,851
Operating lease liabilities	33,139		—		23,302		—
Expense accruals	27,109		—		26,428		—
Inventories	737		—		2,199		—
Provision for receivables	2,365		—		2,345		—
Deferred revenue	12,430		—		11,582		—
Operating loss carryforwards	129,675		—		128,412		—
Tax credit carryforwards	11,822		—		8,104		—
Pensions	—		7,734		—		7,885
Currency adjustments	1,454		—		98		—
Section 163(j) disallowed interest expense	56,019		—		40,054		—
Research and development	—		—		8,236		—
Stock based compensation	8,691		—		7,968		—
Other	3,026		—		1,524		—
Subtotal	286,467		86,464		260,252		78,552
Valuation allowance	(210,273)		—		(196,776)		—
Total deferred income taxes	$	76,194	$	86,464	$	63,476	$	78,552

(a)Does not include approximately $1 billion of statutory loss carryforwards within Luxembourg for which the Company considers the utilization of these attributes remote and, as such, approximately $230 million of a deferred tax asset or corresponding valuation allowance has not been recorded.

Tax Years Subjected to Examniation

The tax years that remain subject to examination for the Company's major tax jurisdictions as of December 31, 2025 are shown below:

Jurisdiction	Earliest Open Year
Brazil	2021
China	2020
France	2023
United States:
Federal income tax	2022
State income tax	2019

The following table reflects the changes in the Company's valuation allowance related to its deferred tax assets:

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the change in the unrecognized income tax benefits balance from January 1, 2023 to December 31, 2025 is as follows:

(In thousands)	Unrecognized Income Tax Benefits		Deferred Income Tax Benefits		Unrecognized Income Tax Benefits, Net of Deferred Income Tax Benefits
Balances, January 1, 2023	$	4,386	$	(21)	$	4,365
Additions for tax positions related to the current year (includes currency translation adjustment)	2,895		(1)		2,894
Statutes of limitation expirations	(1,106)		5		(1,101)
Balance at December 31, 2023	6,175		(17)		6,158
Additions for tax positions related to the current year (includes currency translation adjustment)	228		9		237
Statutes of limitation expirations	(577)		—		(577)
Balance at December 31, 2024	5,826		(8)		5,818
Additions for tax positions related to the current year (includes currency translation adjustment)	619		—		619
Statutes of limitation expirations	(670)		8		(662)
Total unrecognized income tax benefits that, if recognized, would impact the effective income tax rate at December 31, 2025	$	5,775	$	—	$	5,775

Schedule of Income Taxes Paid

Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2, Recently Adopted and Recently Issued Accounting Standards, cash paid for income taxes, net of refunds, during the year ended December 31, 2025 was as follows:

(in thousands)	2025
U.S. federal	$	707
U.S. state and local	1,271
International:
China	5,791
India	5,253
Egypt	1,831
Other foreign jurisdictions	9,171
Total	$	24,024